| Document |
Document Title |
|
WO/2018/060354A1 |
The present invention relates to compounds of formula (I) and to pharmaceutical compositions containing them, wherein meanings of the substituents are indicated in the description. Such compounds for use in the treatment of cancer and ot...
|
|
WO/2018/056237A1 |
Provided are a new dielectric material and an electrostrictive material. The dielectric material or electrostrictive material comprises a charge separated-type non-coulombic ionic solid in which complex cations comprising metal elements ...
|
|
WO/2018/033493A1 |
The present invention relates to liquid aromatic thioethers, a process for the preparation of the liquid aromatic thioethers, an article comprising the liquid aromatic thioethers as well as the use of the liquid aromatic thioethers as a ...
|
|
WO/2018/028050A1 |
Disclosed is an asymmetric aryl-alkyl persulfate compound as represented by formula (3) and a synthesis method therefor, in which an arylboronic acid of formula (1) and R2SSCOR3 of formula (2) serve as reaction raw materials and, under t...
|
|
WO/2018/030816A1 |
The present invention relates to a novel compound exhibiting anti-oxidative or anti-inflammatory activity and a preparing method therefor, a pharmaceutical composition comprising the compound or a salt thereof as an active ingredient for...
|
|
WO/2018/022871A1 |
Embodiments are directed to terphenyl ligands and metal complex formed therefrom, wherein the metal complexes are used as procatalyst in polyolefin polymerization and comprise the following structure:
|
|
WO/2018/021338A1 |
The present invention is a method for producing a specific α-amino acid in which a specific α-amino acid amide and water are reacted with each other in the presence of a zirconium compound, wherein the zirconium compound contains zirco...
|
|
WO/2017/067497A9 |
Disclosed are a monosubstituted or polysubstituted amphiphilic hypocrellin derivative, preparation method therefor, and uses thereof. In the present invention, the amphiphilic hypocrellin derivative having substituted functional groups s...
|
|
WO/2018/015797A1 |
An object of the present invention is to provide a benzylamide compound or a salt thereof that controls a mite. The present invention provides a benzylamide compound represented by Formula (1): or a salt thereof, wherein R1 represents C1...
|
|
WO/2018/015852A1 |
An object of the present invention is to provide a benzylamide compound or a salt thereof that controls a mite. The present invention provides a benzylamide compound represented by Formula (1): or a salt thereof, wherein R1 represents C1...
|
|
WO/2018/003059A1 |
Provided is a method for preparing a polythiol compound, the method comprising: step 1 for reacting 2-mercaptoethanol, which has a water content of 3000 ppm or less on a mass basis, with epihalohydrin to obtain a halide represented by fo...
|
|
WO/2017/221620A1 |
Provided are: a curable composition which has excellent light exposure sensitivity and enables the achievement of a cured film that exhibits excellent adhesion to a supporting body; a cured film; a color filter; a light-blocking film; a ...
|
|
WO/2017/206703A1 |
A methionine new crystal form I, the crystal form II having diffraction peaks at 21.751±0.2°, 22.168±0.2°, 21.186±0.2°, 25.426±0.2°, 18.395±0.2°, and 32.879±0.2° at the diffraction angle 2θ. The methionine crystal form I of ...
|
|
WO/2017/206704A1 |
A methionine new crystal form II, the crystal form II having diffraction peaks at 22.304±0.2°, 33.757±0.2°, 45.674±0.2°, 28.104±0.2°, 18.615±0.2°, and 42.739±0.2° at the diffraction angle 2θ. The methionine crystal form II o...
|
|
WO/2017/206801A1 |
Disclosed are a class of diarylsulfide derivatives, a preparation method therefor, and the use thereof as a serotonin transporter-targeted imaging agent, belonging to the field of radiopharmaceutical chemistry. The diarylsulfide derivati...
|
|
WO/2017/202266A1 |
The present invention relates to a 2-amino-3-substituted mercaptopropionate derivative, a preparation method therefor and a use thereof. The 2-amino-3-substituted mercaptopropionate derivative according to the present invention has a str...
|
|
WO/2017/195149A1 |
Provided are IDO inhibitor compounds of Formula I and pharmaceutically acceptable salts thereof, their pharmaceutical compositions, their methods of preparation, and methods for their use in the prevention and/or treatment of diseases.
|
|
WO/2017/191196A1 |
There is provided a method of producing a method of producing methionine, the method comprising - contacting vinylglycine or derivatives thereof with at least one free radical methyl mercaptanin a reaction medium.
|
|
WO/2017/191195A1 |
There is provided a method of producing at least one unsaturated amino acid from at least one amino acid comprising at least two carbonyl groups, the method comprising (a) contacting a recombinant microbial cell with a medium comprising ...
|
|
WO/2017/188297A1 |
Provided is a resist composition that improves acid generation efficiency and is used to produce a photoresist having high sensitivity, high resolution, and high LWR properties. The present invention relates to a compound represented by ...
|
|
WO/2017/187859A1 |
The present invention is a compound represented by formula (1), a liquid crystal composition containing the compound, and a liquid crystal display element including the composition. In the formula: R is a C1-15 alkyl or the like; ring A1...
|
|
WO/2017/169819A1 |
A black photosensitive resin composition which contains: a photopolymerization initiator composition (A) that contains 1-99 parts by mass of the component (A-1) described below and 1-99 parts by mass of the component (A-2) described belo...
|
|
WO/2017/170952A1 |
The present invention relates to: a novel compound that is useful as a ligand in a variety of catalytic organic synthetic reactions; a method for easily and efficiently producing said novel compound; a synthetic intermediate of said nove...
|
|
WO/2017/162122A1 |
Disclosed herein are novel compounds and uses thereof. The present compounds may suppress the activity of farnesyl transferase and thus, may act as modulators of immune cells; therefor, they are useful for the development of a medicament...
|
|
WO/2017/159552A1 |
A high-purity polyfunctional thiol compound is obtained by a method for producing a polyfunctional thiol compound, the method including a step for reacting a compound represented by general formula (11) and a compound represented by HN(R...
|
|
WO/2017/153235A1 |
The invention relates to novel substituted N-cyclo-3-aryl-1-naphthamide derivatives, to methods for producing same, to the use thereof, either alone or in combination, for the treatment and/or prevention of diseases, and to their use for...
|
|
WO/2017/152539A1 |
Provided are a 4-sulfur pentafluoride phenol compound and a preparation method therefor, and a preparation method for a sulfur pentafluoride substituted benzopyran compound. According to the present invention, sulfur pentafluoride salicy...
|
|
WO/2017/155288A1 |
The present invention relates to a polyethylene glycol derivative and use thereof.
|
|
WO/2017/150478A1 |
[Problem] To provide an industrially preferred method for producing a sulfoxide derivative. [Solution] A method for producing a sulfoxide derivative represented by general formula (1), the method being characterized in that a sulfide der...
|
|
WO/2017/140733A1 |
A compound of formula (I) wherein R1, R2, R3 and R4 can be independently selected from H or Me, n = 0, 1, the dotted lines are indicating single bonds, or in case n = 0 an isolated double bond at position 3', or in case n = 1 an isolated...
|
|
WO/2017/140665A1 |
The present invention relates to a method for preparing 3-methylthiopropionaldehyde by reacting methyl mercaptan with acrolein, in which deviations in the stoichiometry of methyl mercaptan to acrolein in the reaction to give 3-methylthio...
|
|
WO/2017/134190A1 |
Herein is reported a deep eutectic solvent consisting of (2-hydroxyethyl) trimethyl ammonium chloride and dithiothreitol in a molar ratio of from 1:2 to 1:3 and of from 0 % to 10 % co-solvent.
|
|
WO/2017/125673A1 |
The invention relates to a method for preparing a compound (I) or one of the salts thereof, and the uses of said method, R1OOC-C(=X)-CHR2 R3 (I), wherein X is selected among O; N-R', wherein R' is H or a C1-C6 alkyl; and N-OR'' wherein R...
|
|
WO/2017/122822A1 |
The present invention addresses the problem of providing an industrially advantageous method for producing an optically active amidocarboxylic acid derivative, which is an important intermediate of a depsipeptide compound expected to be ...
|
|
WO/2017/109178A1 |
A subject of the present invention is the use of a compound having the general formula (I): (I) wherein V, W, X4, X5, X6, X7, X'4, X'5, X'6, X'7, Y, Y', R3, R'3, R4 and R'4 are as defined in any one of claims 1 to 11, for the detection, ...
|
|
WO/2017/112574A1 |
Pharmaceutical compositions for treating, mitigating or preventing kidney stone disease, bladder stone disease or ureter stone disease are described, the compositions comprising a reducing agent capable of undergoing thiol-disulfide exch...
|
|
WO/2017/096450A1 |
The present invention describes new derivatives of S-allyicysteine with antioxidant and antiaging activity. Said derivatives can be used alone or in a combined formulation with other compounds with known activity.
|
|
WO/2017/100602A1 |
Disclosed herein are methods of preparing an aminimide. An epoxy compound is reacted with a hydrazine compound comprising a trivalent nitrogen, and an anhydride functional material or a cyclic compound containing a carbonyl group and at ...
|
|
WO/2017/097872A1 |
The invention relates to compounds of general formula (I), where the groups R1 and R2 independently have the meaning (CH2)n , n being an integer between 1 and 10, and R3 and R4 independently represent an alkyl group containing 1 to 10 C ...
|
|
WO/2017/095873A1 |
A process includes reacting, in a reactor having a fixed bed containing a solid catalyst which contains a heterogeneous ion exchange resin, hydrogen sulfide and ethylene oxide in the presence of the solid catalyst to yield a reaction pro...
|
|
WO/2017/093172A1 |
Disclosed is a method for producing 2-alkyl-4-trifluoromethyl-3-alkyl sulfonyl benzoic acids of formula (I). In said formula, the substituents represent groups such as alkyl and substituted phenyl.
|
|
WO/2017/093732A1 |
The invention relates to lipid compounds of formula (I) and their pharmaceutically acceptable salts for the prevention and/or treatment of ophthalmic disorders such as retinal degenerative disorders and ocular inflammatory diseases: (I) ...
|
|
WO/2017/081122A1 |
Process for treating keratin fibres with a cationic disulfide compound The invention relates to a process for treating keratin fibres, in particular human keratin fibres such as the hair, comprising: (i) a step of applying a compound (I)...
|
|
WO/2017/083243A1 |
Thioether-substituted phenols that are the reaction product of a thioether-substituted alcohol or thioether-substituted amine and a phenol with at least one pendant acyl group and have a ratio of sulfur groups to phenol groups of at leas...
|
|
WO/2017/072343A1 |
The invention relates to a compound that can be produced according to a method comprising at least one step of polymerisation of at least one monomer of formula (I), said step of polymerisation being carried out in the presence of a cata...
|
|
WO/2017/067500A1 |
The invention relates to the field of mite killers, and specifically, to a biphenyl compound and application thereof. The structure is expressed by formula I, and each substituent in the formula is defined in the specification. The formu...
|
|
WO/2017/070482A2 |
PPSMA binding scaffolds with radioiodinated, radiobrominated and radioastatinated labeled prosthetic groups are disclosed. Pharmaceutical compositions and methods of treating PSMA expressing cells or tumors also are disclosed.
|
|
WO/2017/064250A1 |
The present invention relates to an industrial process for the preparation of (5S,10S)-10- benzyl-16-methyl-11,14,18-trioxo-15,17,19-trioxa-2,7,8-trith
ia-12-azahenicosan-5-aminium (E)-3-carboxyacrylate salt of following formula (I) : wh...
|
|
WO/2017/050314A1 |
The invention relates to a compound having the chemical formula (I), wherein R1 represents the amino acids 1-120 of beta-lactoglobulin and R2 the amino acids 122-162 of beta-lactoglobulin from cow's milk. The invention further relates to...
|
|
WO/2017/053360A1 |
Histone deacetylases inhibitors (HDACIs) and compositions containing the same are disclosed. Methods of treating diseases and conditions wherein inhibition of HDAC provides a benefit, like a cancer, a neurodegenerative disorder, a periph...
|
